Genolution Non-Registered Executive Woojin Kim Increases Stake to 0.11% via Open Market Purchase

Non-Registered Executive Woojin Kim, Managing Director of Genolution, acquired 4,360 common shares at 1,100 KRW per share via open market purchase on June 29, 2026.
Following this acquisition, Kim's total holdings amount to 22,000 shares representing a 0.11% stake, up from 0.09% previously.
This report reflects a minor insider ownership change with no material impact on the company's capital structure or shareholder value.
[AI Summary]A small open market purchase by a non-registered executive signals insider confidence but the scale is negligible for stock price impact. No changes to corporate capital policy or dividends; investors should focus on broader fundamentals.